APE1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Addex Therapeutics Ltd

Watchlist Manager

Watchlist

Price: 2.86 EUR 3.62% Market Closed

Market Cap: €625.3m

	Addex Therapeutics Ltd F:APE1	CH
	Ipsos SA F:IPZ	FR

Profitability Summary

Addex Therapeutics Ltd's profitability score is 7/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-2,455%

Negative 3Y Average Operating Margin

-825%

Declining Operating Margin

-580% > -2,455%

Negative Net Margin

-6,363%

Negative 3Y Average Net Margin

-921%

Declining Net Margin

-624% > -6,363%

Negative Free Cash Flow Margin

-2,135%

Negative 3Y Average Free Cash Flow Margin

-878%

Declining Free Cash Flow Margin

-422% > -2,135%

Negative ROE

-120%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-54%

Declining ROIC

15,794% > -56%

View All

Hide

Collapse

7 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.